U

Urteste SA
WSE:URT

Watchlist Manager
Urteste SA
WSE:URT
Watchlist
Price: 92 PLN 4.07% Market Closed
Market Cap: 129.7m PLN
Have any thoughts about
Urteste SA?
Write Note

P/E
Price to Earnings

-30.3
Current
-26.3
Median
22.1
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-30.3
=
Market Cap
129.7m PLN
/
Net Income
-4.3m PLN
All Countries
Close
Market Cap P/E
PL
Urteste SA
WSE:URT
129.7m PLN -30.3
FR
Pharnext SCA
OTC:PNEXF
6T USD -181 287
US
Abbvie Inc
NYSE:ABBV
314.9B USD 62.1
US
Amgen Inc
NASDAQ:AMGN
140.6B USD 33.4
US
Gilead Sciences Inc
NASDAQ:GILD
115.7B USD 920.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.9B USD -218.6
US
Epizyme Inc
F:EPE
94.1B EUR -471.3
AU
CSL Ltd
ASX:CSL
135.7B AUD 32.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.8B USD 16.8
US
Seagen Inc
F:SGT
39.3B EUR -54.6
NL
argenx SE
XBRU:ARGX
36B EUR -135.3
Earnings Growth P/E to Growth
PL
U
Urteste SA
WSE:URT
Average P/E: 213
Negative Multiple: -30.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 287 N/A N/A
US
Abbvie Inc
NYSE:ABBV
62.1
413%
0.2
US
Amgen Inc
NASDAQ:AMGN
33.4
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
920.7
77%
11.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -218.6
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -471.3 N/A N/A
AU
CSL Ltd
ASX:CSL
32.1
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -135.3 N/A N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
N/A
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A

See Also

Discover More